pyrazolones - CISMeF

Preferred Label : pyrazolones;

MeSH definition : Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.;

MeSH hyponym : Pyrazolin-5-Ones; Pyrazolin 5 Ones;

Wikipedia link : https://en.wikipedia.org/wiki/Pyrazolones;

Is substance : O;

Détails

Origin ID

D047069;

UMLS CUI

C1449668;

ATC code(s)
- pyrazolones [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Pyrazolone derivatives [ICHI section]
- pyrazolone derivatives [ATC Code]
- pyrazolones [ATC Code]
Record concept(s)
- Pyrazolin-5-Ones [MeSH concept]
- pyrazolones [MeSH concept]
Related MeSH Supplementary Concept(s)
- (Z)-3-methyl-4-(2-(4-methylphenyl)hydrazinylidene)-1-(pentafluorophenyl)-1H-pyrazol-5(4H)-one [MeSH Supplementary Concept]
- 1,3-diphenyl-4-(4'-fluro)benzal-5-pyrazolone-4-ethyl thiosemicarbazone [MeSH Supplementary Concept]
- 1-(2-naphthyl)-3-methyl-5-pyrazolone [MeSH Supplementary Concept]
- 1-(3'-iodophenyl)-3-methy-2-pyrazolin-5-one [MeSH Supplementary Concept]
- 1-(4-isopropyl)phenyl-3-methyl-5-pyrazolone [MeSH Supplementary Concept]
- 1-(4-methoxy)phenyl-3-methyl-5-pyrazolone [MeSH Supplementary Concept]
- 1-(n-decyl)-3-pyrazolidinone [MeSH Supplementary Concept]
- 1-n-butyl-5-(4-chlorophenyl)-3-pyrazolidinone [MeSH Supplementary Concept]
- 1-nitrophenyl-3-methyl-4-(5'-nitrofurfuryl)pyrazol-5-one [MeSH Supplementary Concept]
- 1-phenyl-2,3-dimethyl-4-iodopyrazolone [MeSH Supplementary Concept]
- 1-phenyl-2,3-dimethyl-4-naphthalanmorpholinomethylpyrazolin-5-one [MeSH Supplementary Concept]
- 1-phenyl-3-methyl-4-(5'-nitrofurfuryl)-pyrazol-5-one [MeSH Supplementary Concept]
- 3-methyl-1-(pyridin-2-yl)-5-pyrazolone [MeSH Supplementary Concept]
- 3-methyl-4-((Z)-2-(4-methylphenyl)hydrazin-1-ylidene)-1-(3-nitrophenyl)-1H-pyrazol-5(4H)-one [MeSH Supplementary Concept]
- 3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one [MeSH Supplementary Concept]
- 3-methylpyrazolin-5(4H)-one-4-(3'-methoxy-4'-(2'',3'',4'',6''-tetra-O-acetylglycopyranosyl))benzylidene [MeSH Supplementary Concept]
- 4,4-dimethylpyrazolone [MeSH Supplementary Concept]
- 4-((4-hydroxy-3-fluoro-5-methoxybenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydropyrazol-3-one [MeSH Supplementary Concept]
- 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid [MeSH Supplementary Concept]
- 4-(4-chlorophenylazo)-3-methyl-1-(2-hydroxy-3-morphilinopropan-1-yl)-2-pyrazolin-5-one [MeSH Supplementary Concept]
- 4-amino-1-phenylpyrazolone [MeSH Supplementary Concept]
- 4-benzoyl-3-methyl-1-phenyl-pyrazol-5-one [MeSH Supplementary Concept]
- 4-vinyl-3-pyrazolidinone [MeSH Supplementary Concept]
- 5-amino-1-(4-methylphenylsulfonyl)-4-pyrazolin-3-one [MeSH Supplementary Concept]
- 5-aminomethylpyrazolin-5-one [MeSH Supplementary Concept]
- 5-vinyl-1,2-diphenyl-4-methylenepyrazolidin-3-one [MeSH Supplementary Concept]
- BTS 71 412 [MeSH Supplementary Concept]
- CC 401 [MeSH Supplementary Concept]
- L.N. 1520 [MeSH Supplementary Concept]
- MEDS433 [MeSH Supplementary Concept]
- N(1)-isonicotinoyl-3-methyl-4-(4-hydroxybenzilidene)-2-pyrazolin-5-one [MeSH Supplementary Concept]
- N-(4-chlorophenyl)-N'-(5-isopropyl-1-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)urea [MeSH Supplementary Concept]
- PK 144 [MeSH Supplementary Concept]
- PZ-II-029 [MeSH Supplementary Concept]
- caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination [MeSH Supplementary Concept]
- dihydrotrifluoromethylbenzothiopyranopyrazolone [MeSH Supplementary Concept]
- famprofazone [MeSH Supplementary Concept]
- hetrombopag [MeSH Supplementary Concept]
- losoxantrone [MeSH Supplementary Concept]
- nafazatrom [MeSH Supplementary Concept]
- nostocine A [MeSH Supplementary Concept]
- picrolonic acid [MeSH Supplementary Concept]
- pyrano (3,2-b)pyrazolo(4,3-e)pyridin-8(1H)-one [MeSH Supplementary Concept]
- pyrazolone [MeSH Supplementary Concept]
- pyrrolo(3,4-c)pyrazole-4,6-dione [MeSH Supplementary Concept]
- revenast [MeSH Supplementary Concept]
- setanaxib [MeSH Supplementary Concept]
- simurosertib [MeSH Supplementary Concept]
- sudan yellow 3G [MeSH Supplementary Concept]
- technetium tc 99m-4-methylaminophenazone [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Pyrazolone derivatives [Bloc CIM-11]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients